Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert S Warren

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Seminars in Oncology|February 24, 2005
Liver-directed therapies in colorectal cancerDaniel T Ruan, Robert S Warren
Surgical Oncology Clinics of North America|July 9, 2004
Palliative techniques for hepatic cancerDaniel T Ruan, Robert S Warren
Surgical Oncology|September 15, 2007
Palliative care for patients with advanced pancreatic and biliary cancersEric K Nakakura, Robert S Warren
Surgical Oncology Clinics of North America|December 19, 2002
Liver-directed viral therapy for cancer p53-targeted adenoviruses and beyondRobert S Warren, David H Kirn
Surgical Oncology|November 24, 2007
IntroductionRobert S Warren, Eric K Nakakura
Journal of Biochemical and Molecular Toxicology|May 4, 2004
Characterization of triacsin C inhibition of short-, medium-, and long-chain fatty acid: CoA ligases of human liverDonald A Vessey, Michael Kelley, Robert S Warren
Oncotarget|August 25, 2015
Unexpected insights for anti-EGFR cancer therapyPhilippe Depeille, Robert S Warren, Jeroen P Roose
Journal of the American College of Surgeons|November 20, 2002
Thorotrast-induced liver neoplasia: a collective reviewGerald S Lipshutz, Todd V Brennan, Robert S Warren
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
Is there currently an established role for the use of predictive or prognostic molecular markers in the management of colorectal cancer? A point/counterpointAlan P Venook, Johanna C Bendell, Robert S Warren
Journal of Biochemical and Molecular Toxicology|March 5, 2003
Isolation, sequencing, and expression of a cDNA for the HXM-A form of xenobiotic/medium-chain fatty acid:CoA ligase from human liver mitochondriaDonald A Vessey, Eva Lau, Michael Kelley, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Seminars in Oncology|February 24, 2005
Liver-directed therapies in colorectal cancerDaniel T Ruan, Robert S Warren
Surgical Oncology Clinics of North America|July 9, 2004
Palliative techniques for hepatic cancerDaniel T Ruan, Robert S Warren
Surgical Oncology|September 15, 2007
Palliative care for patients with advanced pancreatic and biliary cancersEric K Nakakura, Robert S Warren
Surgical Oncology Clinics of North America|December 19, 2002
Liver-directed viral therapy for cancer p53-targeted adenoviruses and beyondRobert S Warren, David H Kirn
Surgical Oncology|November 24, 2007
IntroductionRobert S Warren, Eric K Nakakura
Journal of Biochemical and Molecular Toxicology|May 4, 2004
Characterization of triacsin C inhibition of short-, medium-, and long-chain fatty acid: CoA ligases of human liverDonald A Vessey, Michael Kelley, Robert S Warren
Oncotarget|August 25, 2015
Unexpected insights for anti-EGFR cancer therapyPhilippe Depeille, Robert S Warren, Jeroen P Roose
Journal of the American College of Surgeons|November 20, 2002
Thorotrast-induced liver neoplasia: a collective reviewGerald S Lipshutz, Todd V Brennan, Robert S Warren
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
Is there currently an established role for the use of predictive or prognostic molecular markers in the management of colorectal cancer? A point/counterpointAlan P Venook, Johanna C Bendell, Robert S Warren
Journal of Biochemical and Molecular Toxicology|March 5, 2003
Isolation, sequencing, and expression of a cDNA for the HXM-A form of xenobiotic/medium-chain fatty acid:CoA ligase from human liver mitochondriaDonald A Vessey, Eva Lau, Michael Kelley, et al.
Pageof 6